Used primarily in research and experimental settings, Thalidomide-C2-amido-C2-COOH is a derivative studied for its potential in targeted drug delivery systems. Its structure, featuring an amido linker and carboxylic acid group, allows for the attachment to specific biomolecules, enhancing the precision of therapeutic agents. It is also explored in the development of novel treatments for inflammatory diseases and certain cancers, leveraging thalidomide's ability to modulate immune responses and inhibit angiogenesis. Additionally, it serves as a key intermediate in the synthesis of more complex pharmaceutical compounds, contributing to advancements in medicinal chemistry.